Evidence map›Paper›PMID 40995462›Full record

ArticleImaging neuroscience (Cambridge, Mass.)2025

Acetaminophen affects the duration but not the occurrence of BOLD signal decline in the dorsal hippocampus after induction of neuronal afterdischarges.

Alberto Arboit, Karla Krautwald, Frank Angenstein

Abstract read
In one paragraph

Article in Imaging neuroscience (Cambridge, Mass.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alberto ArboitFunctional Neuroimaging Group, Deutsches Zentrum für neurodegenerative Erkrankungen (DZNE), Magdeburg, Germany.ORCID https://orcid.org/0000-0002-9918-2080
Karla KrautwaldFunctional Neuroimaging Group, Deutsches Zentrum für neurodegenerative Erkrankungen (DZNE), Magdeburg, Germany.
Frank AngensteinFunctional Neuroimaging Group, Deutsches Zentrum für neurodegenerative Erkrankungen (DZNE), Magdeburg, Germany.ORCID https://orcid.org/0000-0003-1157-714X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Combined in vivo electrophysiological and functional magnetic resonance imaging (fMRI) measurements were used to monitor neuronal and hemodynamic responses in the right dorsal hippocampus during and after electrical stimulation of the right perforant pathway with a short period of 20 Hz pulses. These measurements were performed under two conditions: 1.5% isoflurane (which has a long-term vasodilator effect) or 100 µg/kg medetomidine (which has a long-term vasoconstrictor effect). The stimulation elicited a short period of neuronal afterdischarges (nAD) followed by a sustained decline in fMRI BOLD signals, as previously described (Arboit et al., 2024). While the duration of nAD was similar in presence of isoflurane and medetomidine, the subsequent decline of BOLD signal was significantly longer with isoflurane than with medetomidine. However, when the same experiments were performed in the presence of acetaminophen, the duration of the sustained decline of BOLD signals became similar: acetaminophen significantly prolonged the decline in the presence of medetomidine, whereas it only slightly shortened it in the presence of isoflurane. As acetaminophen did not affect the generation and intensity of nAD, the results indicate that nAD activates at least two different neurovascular coupling (NVC) mechanisms that mediate the sustained BOLD signal decline, of which acetaminophen affects the maintenance.

Indexed as

BOLD-fMRIdentate gyrusin vivo electrophysiologynegative BOLD responseneurovascular coupling

Identifiers

PMID40995462
PMCPMC12455054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.